Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126037411 | 12603741 | 1 | I | 201508 | 20150914 | 20160728 | 20160728 | PER | US-MYLANLABS-2015M1031540 | MYLAN | 50.80 | YR | F | Y | 68.27000 | KG | 20160728 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126037411 | 12603741 | 1 | PS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | Oral | 100 ?G, QD | 76187 | 100 | UG | TABLET | QD | ||||||
| 126037411 | 12603741 | 2 | C | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG/12.5MG., QD | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126037411 | 12603741 | 1 | Hypothyroidism |
| 126037411 | 12603741 | 2 | Blood pressure measurement |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126037411 | 12603741 | Fatigue | |
| 126037411 | 12603741 | Feeling abnormal | |
| 126037411 | 12603741 | Headache | |
| 126037411 | 12603741 | Muscle spasms |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126037411 | 12603741 | 1 | 2013 | 0 | ||
| 126037411 | 12603741 | 2 | 2005 | 0 |